Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction: Observations from the TIMI IIIB Trial

Circulation

Volumn 94, Issue 11, 1996, Pages 2749-2755

  Williams, David O ^a,b   Braunwald, Eugene ^a   Thompson, Bruce ^a   Sharaf, Barry L ^a   Buller, Chris E ^a   Knatterud, Genell L ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

angina; angioplasty; infarction; ischemia; thrombolysis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; EMERGENCY SURGERY; FEMALE; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0029822151     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2749     Document Type: Article

References (37)

1. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation. 1994;89:1545-1556.
2. Wohlgelernter D, Cleman M, Highman HA, Zaret BL. Percutaneous transluminal coronary angioplasty of the 'culprit lesion' for management of unstable angina in patients with multivessel coronary artery disease. Am J Cardiol. 1986;58:460-464.
3. The TIMI Study Group. The Thrombolysis in Acute Myocardial Infarction (TIMI) Trial: phase I findings. N Engl J Med. 1985;312: 932-936.
4. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
5. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, 2: analysis and examples. Br J Cancer. 1977;35:1-39.
6. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54: 167-179.
7. Cox DR. Regression models and life tables. J R Stat Soc B. 1972; 34:187-200.
8. Williams DO, Riley RS, Singh AK, Gewirtz H, Most AS. Evaluation of the role of coronary angioplasty in patients with unstable angina pectoris. Am Heart J. 1981;102:1-9.
9. de Feyter PJ, Serruys PW, Suryapranasta H, Beatt K, Van den Brand M. Coronary angioplasty early after diagnosis of unstable angina. Am Heart J. 1987;114:8-54.
10. Safian RD, Snyder BA, McKay RG, Lorell BH, Aroesty JM, Pasternak RC, Bradley AB, Monrad EJ, Baim DS. Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q wave acute myocardial infarction. Am J Cardiol. 1987; 59:263-266.
11. Suryapranata H, Beatt K, de Feyter PJ, Verrostte J, Van den Brand M, Zijlstra F, Serruys PW. Percutaneous transluminal coronary angioplasty for angina pectoris after a non-Q-wave acute myocardial infarction. Am J Cardiol. 1988;61:240-243.
12. Kamp O, Beatt KJ, de Feyter PJ, Van den Brand M, Suryapranata H, Luijten HE, Serruys PW. Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris. Am Heart J. 1989;117:991-996.
13. Morrison DA. Coronary angioplasty for medically refractory unstable angina within 30 days of acute myocardial infarction. Am Heart J. 1990;120:256-261.
14. Stammen F, DeScheereter I, Glazier JJ, Van Lierde J, Vrolly M, Willems JL, De Geest H, Piessens J. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris. Am J Cardiol. 1992;69:1533-1537.
15. Bentivoglio LG, Detre KM, Yen W, Williams DO, Kelsey SF, Faxon DP. Outcome of percutaneous transluminal coronary angioplasty in subjects of unstable angina pectoris: a report from the 1985-1986 National Heart. Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1994;24: 1195-1206.
16. Joelson JM, Most AS, Williams DO. Angiographic findings when chest pain recurs after successful coronary angioplasty. Am J Cardiol. 1987;60:792-798.
17. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre M, Veltri L, Ricci D, Nobuyosni M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Blinker J, Mosses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
18. Fuster V, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
19. Sugrue DD, Holmes DR, Smith H-C, Reeder GS, Lane GE, Vlietstra RE, Bresnahan JF, Hammes LN, Piehler JM. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. Br Heart J. 1986;56:62-67.
20. Ambrose JA, Almeida OD, Sharma SR, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Hjemdahl-Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrell JS, Cowley MJ, Anwar A, Sobolski J. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA Trial. Circulation. 1994;90:69-77.
21. Waller BF, Rothbaum DA, Pinkerton CA, Cowley MJ, Linnemeier JJ, Orr C, Ivons M, Helmuth RA, Wills ER, Aust C. Status of the myocardium and infarct related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase r-tissue plasminogen activator) mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J Am Coll Cardiol. 1987;9:785-801.
22. Eisenberg PR, Snerman LA, Jaffe AS. Paradoxical elevations of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol. 1987;10: 527-535.
23. Aronson DL, Chang P, Kessler CM. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Circulation. 1992; 85:1706-1712.
24. EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
25. Benedict CR, Refino CJ, Keyt BA, Pakala R, Paoni NF, Thomas GR, Bennett WF. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation. 1995;92: 3032-3040.
26. Salinger MH, Lopez A, Frohlich TG, McDonough TJ, Muester DC, Stagl RD. Systemic and local saphenous vein graft thrombolysis using a tissue plasminogen activator. Cathet Cardiovasc Diagn. 1990; 19:198-201.
27. Chapekis AT, George BS, Candela RJ. Rapid thrombus dissolution by continuous infusion of urokinase through an intracoronary perfusion wire prior to and following PTCA: results in native coronaries and saphenous vein grafts. Cathet Cardiovasc Diagn. 1991;23: 89-92.
28. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation. 1985;72: 1044-1052.
29. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MS, Detre KM. Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 1993;87:720-727.
30. Weintraub WS, Wenger NK, Kosinski AS, Douglas JS Jr, Liberman HA, Mornes DC, King SB. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol. 1994; 24:81-90.
31. Kelsey SF, Miller DP, Houlubkov R, Lu AS, Cowley MJ, Faxon DP, Detre KM. Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985-1986 National Heart, Lung and Blood Institute's Coronary Angioplasty Registry). Am J Cardiol. 1990;66:1033-1038.
32. Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB, Gruentzig AR. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986;73:710-717.
33. Halon DA, Merdter A, Shefer A, Flugelman MY, Lewis BS. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. Am J Cardiol. 1989;64:289-293.
34. Williams DO, Baim DS, Bates E, Bonan R, Bost JE, Cowley M, Faxon DP, Feit F, Jones R, Kellet MA Jr, Kelsey SF, Sopko G, Stadius M, Topol EJ. Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1995;75:27C-33C.
35. Meier B. Total coronary occlusion: a different animal? J Am Coll Cardiol. 1991;17(suppl B):50B-57B.
36. Mock MB, Ringquist I, Fisher D, Davis KB, Chaitman BR, Kouch-oukos NJ, Kaiser GC, Alderman E, Ryan TJ, Russel RO, Mullin S, Fray D, Killip T. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1982;66: 562-568.
37. Passamani E, Davis KB, Giliespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665-1671.